The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

Autor: Figlioli, G, Bogliolo, M, Catucci, I, Caleca, L, Lasheras, SV, Pujol, R, Kiiski, JI, Muranen, TA, Barnes, DR, Dennis, J, Michailidou, K, Bolla, MK, Leslie, G, Aalfs, CM, Balleine, R, Baxter, R, Braye, S, Carpenter, J, Dahlstrom, J, Forbes, J, Lee, CS, Marsh, D, Morey, A, Pathmanathan, N, Scott, R, Simpson, P, Spigelman, A, Wilcken, N, Yip, D, Zeps, N, Adank, MA, Adlard, J, Agata, S, Cadoo, K, Agnarsson, BA, Ahearn, T, Aittomäki, K, Ambrosone, CB, Andrews, L, Anton-Culver, H, Antonenkova, NN, Arndt, V, Arnold, N, Aronson, KJ, Arun, BK, Asseryanis, E, Auber, B, Auvinen, P, Azzollini, J, Balmaña, J, Barkardottir, RB, Barrowdale, D, Barwell, J, Beane Freeman, LE, Beauparlant, CJ, Beckmann, MW, Behrens, S, Benitez, J, Berger, R, Bermisheva, M, Blanco, AM, Blomqvist, C, Bogdanova, NV, Bojesen, A, Bojesen, SE, Bonanni, B, Borg, A, Brady, AF, Brauch, H, Brenner, H, Brüning, T, Burwinkel, B, Buys, SS, Caldés, T, Caliebe, A, Caligo, MA, Campa, D, Campbell, IG, Canzian, F, Castelao, JE, Chang-Claude, J, Chanock, SJ, Claes, KBM, Clarke, CL, Collavoli, A, Conner, TA, Cox, DG, Cybulski, C, Czene, K, Daly, MB, de la Hoya, M, Devilee, P, Diez, O, Ding, YC, Dite, GS, Ditsch, N, Domchek, SM, Dorfling, CM, dos-Santos-Silva, I, Durda, K

© 2019, The Author(s). Breast cancer is a common disease partially caused by genetic risk factors. Germline pathogenic variants in DNA repair genes BRCA1, BRCA2, PALB2, ATM, and CHEK2 are associated with breast cancer risk. FANCM, which encodes for

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______363::1eca2560382e9f722375dae0ae46daba
https://hdl.handle.net/10453/137862

Chronic use of non-steroidal anti-inflammatory drugs (NSAIDs) or acetaminophen and relationship with mortality among United States Veterans after testing positive for COVID-19.

Autor: Campbell HM; Cooperative Studies Program, Clinical Research Pharmacy Coordinating Center, US Department of Veterans Affairs, Albuquerque, New Mexico, United States of America., Murata AE; Cooperative Studies Program, Clinical Research Pharmacy Coordinating Center, US Department of Veterans Affairs, Albuquerque, New Mexico, United States of America., Conner TA; Cooperative Studies Program, Clinical Research Pharmacy Coordinating Center, US Department of Veterans Affairs, Albuquerque, New Mexico, United States of America., Fotieo G; New Mexico VA Healthcare System, US Department of Veterans Affairs, Albuquerque, New Mexico, United States of America.

Publikováno v: PloS one [PLoS One] 2022 May 05; Vol. 17 (5), pp. e0267462. Date of Electronic Publication: 2022 May 05 (Print Publication: 2022).

Pentoxifylline in diabetic kidney disease (VA PTXRx): protocol for a pragmatic randomised controlled trial.

Autor: Leehey DJ; Edward Hines Junior VA Hospital, Hines, Illinois, USA david.leehey@va.gov.; Loyola University Medical Center, Maywood, Illinois, USA., Carlson K; Cooperative Studies Program, Edward Hines Junior VA Hospital, Hines, Illinois, USA., Reda DJ; Cooperative Studies Program, Edward Hines Junior VA Hospital, Hines, Illinois, USA., Craig I; Division of Strategic Innovation, Evaluation, and Communication, Center for Clinical Standards and Quality, Baltimore, Maryland, USA., Clise C; VA Cooperative Studies Program, Clinical Research Pharmacy Coordinating Center, Albuquerque, New Mexico, USA., Conner TA; VA Cooperative Studies Program, Clinical Research Pharmacy Coordinating Center, Albuquerque, New Mexico, USA., Agarwal R; Veterans' Affairs Medical Center, Indianapolis, Indiana, USA., Kaufman JS; Research Service, New York Harbor Health Care System, New York, New York, USA., Anderson RJ; Veterans' Affairs Medical Center, Omaha, Nebraska, USA., Lammie D; Cooperative Studies Program, Edward Hines Junior VA Hospital, Hines, Illinois, USA., Huminik J; VA Cooperative Studies Program, Clinical Research Pharmacy Coordinating Center, Albuquerque, New Mexico, USA., Polzin L; Edward Hines Junior VA Hospital, Hines, Illinois, USA., McBurney C; Edward Hines Junior VA Hospital, Hines, Illinois, USA., Huang GD; Veterans Affairs Office of Research and Development, Washington, District of Columbia, USA., Emanuele NV; Edward Hines Junior VA Hospital, Hines, Illinois, USA.

Publikováno v: BMJ open [BMJ Open] 2021 Aug 16; Vol. 11 (8), pp. e053019. Date of Electronic Publication: 2021 Aug 16.

The FANCM :p.Arg658* truncating variant is associated with risk of triple-negative breast cancer.

Autor: Figlioli G; IFOM - the FIRC Institute for Molecular Oncology, Genome Diagnostics Program, Milan, Italy., Bogliolo M; 2Department of Genetics and Microbiology, Universitat Autònoma de Barcelona, Bellaterra, Barcelona Spain.; 3Center for Biomedical Network Research on Rare Diseases (CIBERER), Madrid, Spain.; 4Institute of Biomedical Research, Sant Pau Hospital, Barcelona, Spain., Catucci I; IFOM - the FIRC Institute for Molecular Oncology, Genome Diagnostics Program, Milan, Italy., Caleca L; Fondazione IRCCS Istituto Nazionale dei Tumori, Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Milan, Italy., Lasheras SV; 2Department of Genetics and Microbiology, Universitat Autònoma de Barcelona, Bellaterra, Barcelona Spain., Pujol R; 2Department of Genetics and Microbiology, Universitat Autònoma de Barcelona, Bellaterra, Barcelona Spain.; 3Center for Biomedical Network Research on Rare Diseases (CIBERER), Madrid, Spain.; 4Institute of Biomedical Research, Sant Pau Hospital, Barcelona, Spain., Kiiski JI; University of Helsinki, Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland., Muranen TA; University of Helsinki, Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland., Barnes DR; 7University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK., Dennis J; 7University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK., Michailidou K; 7University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK.; The Cyprus Institute of Neurology & Genetics, Department of Electron Microscopy/Molecular Pathology and The Cyprus School of Molecular Medicine, Nicosia, Cyprus., Bolla MK; 7University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK., Leslie G; 7University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK., Aalfs CM; 9Amsterdam UMC, lokatie AMC, Department of Clinical Genetics, Amsterdam, The Netherlands., Adank MA; The Netherlands Cancer Institute - Antoni van Leeuwenhoek hospital, Family Cancer Clinic, Amsterdam, The Netherlands., Adlard J; Chapel Allerton Hospital, Yorkshire Regional Genetics Service, Leeds, UK., Agata S; Veneto Institute of Oncology IOV - IRCCS, Immunology and Molecular Oncology Unit, Padua, Italy., Cadoo K; Memorial Sloan-Kettering Cancer Center, Department of Medicine, New York, NY USA., Agnarsson BA; Landspitali University Hospital, Department of Pathology, Reykjavik, Iceland.; 15University of Iceland, School of Medicine, Reykjavik, Iceland., Ahearn T; 16National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Division of Cancer Epidemiology and Genetics, Bethesda, MD USA., Aittomäki K; 17University of Helsinki, Department of Clinical Genetics, Helsinki University Hospital, Helsinki, Finland., Ambrosone CB; 18Roswell Park Cancer Institute, Buffalo, NY USA., Andrews L; Nelune Comprehensive Cancer Care Centre, The Bright Alliance Building, Randwick, NSW Australia., Anton-Culver H; 20University of California Irvine, Department of Epidemiology, Genetic Epidemiology Research Institute, Irvine, CA USA., Antonenkova NN; N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus., Arndt V; German Cancer Research Center (DKFZ), Division of Clinical Epidemiology and Aging Research, Heidelberg, Germany., Arnold N; University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Department of Gynaecology and Obstetrics, and Institute of Clinical Molecular Biology, Kiel, Germany., Aronson KJ; Queen's University, Department of Public Health Sciences, and Cancer Research Institute, Kingston, ON Canada., Arun BK; 25University of Texas MD Anderson Cancer Center, Department of Breast Medical Oncology, Houston, TX USA., Asseryanis E; 26Medical University of Vienna, Dept of OB/GYN and Comprehensive Cancer Center, Vienna, Austria., Auber B; 27Hannover Medical School, Institute of Human Genetics, Hannover, Germany., Auvinen P; 28Kuopio University Hospital, Cancer Center, Kuopio, Finland.; 29University of Eastern Finland, Institute of Clinical Medicine, Oncology, Kuopio, Finland.; 30University of Eastern Finland, Translational Cancer Research Area, Kuopio, Finland., Azzollini J; 31Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Department of Medical Oncology and Hematology, Unit of Medical Genetics, Milan, Italy., Balmaña J; 32Vall d'Hebron Institute of Oncology, High Risk and Cancer Prevention Group, Barcelona, Spain.; 33University Hospital, Vall d'Hebron, Department of Medical Oncology, Barcelona, Spain., Barkardottir RB; Landspitali University Hospital, Department of Pathology, Reykjavik, Iceland.; 34University of Iceland, BMC (Biomedical Centre), Faculty of Medicine, Reykjavik, Iceland., Barrowdale D; 7University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK., Barwell J; 35University Hospitals of Leicester NHS Trust, Leicestershire Clinical Genetics Service, Leicester, UK., Beane Freeman LE; 16National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Division of Cancer Epidemiology and Genetics, Bethesda, MD USA., Beauparlant CJ; 36Centre Hospitalier Universitaire de Québec - Université Laval, Research Center, Genomics Center, Québec City, QC Canada., Beckmann MW; University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, Erlangen, Germany., Behrens S; German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany., Benitez J; Spanish National Cancer Research Centre (CNIO), Human Genetics Group, Human Cancer Genetics Programme, Madrid, Spain.; 40Spanish Network on Rare Diseases (CIBERER), Madrid, Spain.; 41Spanish National Cancer Research Centre (CNIO), Genotyping Unit (CEGEN), Human Cancer Genetics Programme, Madrid, Spain., Berger R; Chaim Sheba Medical Center, The Institute of Oncology, Ramat Gan, Israel., Bermisheva M; 43Ufa Federal Research Center of the Russian Academy of Sciences, Institute of Biochemistry and Genetics, Ufa, Russia., Blanco AM; 44University of California San Francisco, Cancer Genetics and Prevention Program, San Francisco, CA USA., Blomqvist C; University of Helsinki, Department of Oncology, Helsinki University Hospital, Helsinki, Finland.; 46Örebro University Hospital, Department of Oncology, Örebro, Sweden., Bogdanova NV; N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus.; Hannover Medical School, Department of Radiation Oncology, Hannover, Germany.; Hannover Medical School, Gynaecology Research Unit, Hannover, Germany., Bojesen A; 49Aarhus University Hospital, Department of Clinical Genetics, Aarhus, Denmark., Bojesen SE; Copenhagen University Hospital, Copenhagen General Population Study, Herlev and Gentofte Hospital, Herlev, Denmark.; Copenhagen University Hospital, Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Herlev, Denmark.; 52University of Copenhagen, Faculty of Health and Medical Sciences, Copenhagen, Denmark., Bonanni B; 53IEO, European Institute of Oncology IRCCS, Division of Cancer Prevention and Genetics, Milan, Italy., Borg A; 54Lund University and Skåne University Hospital, Department of Oncology, Lund, Sweden., Brady AF; 55London North West University Hospitals NHS Trust, Northwick Park Hospital, North West Thames Regional Genetics Service, Kennedy Galton Centre, Harrow, UK., Brauch H; 56Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.; 57University of Tübingen, iFIT-Cluster of Excellence, Tübingen, Germany.; 58German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany., Brenner H; German Cancer Research Center (DKFZ), Division of Clinical Epidemiology and Aging Research, Heidelberg, Germany.; 58German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.; 59German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Division of Preventive Oncology, Heidelberg, Germany., Brüning T; 60Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum, Bochum, Germany., Burwinkel B; 61German Cancer Research Center (DKFZ), Molecular Epidemiology Group, C080 Heidelberg, Germany.; University of Heidelberg, Molecular Biology of Breast Cancer, University Womens Clinic Heidelberg, Heidelberg, Germany., Buys SS; 63Huntsman Cancer Institute, Department of Medicine, Salt Lake City, UT USA., Caldés T; 64Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Medical Oncology Department, Hospital Clínico San Carlos, Madrid, Spain., Caliebe A; University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Institute of Human Genetics, Kiel, Germany., Caligo MA; 66University Hospital of Pisa, Section of Molecular Genetics, Dept. of Laboratory Medicine, Pisa, Italy., Campa D; German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany.; 67University of Pisa, Department of Biology, Pisa, Italy., Campbell IG; 68Peter MacCallum Cancer Center, Research Division, Melbourne, VIC Australia.; 69The University of Melbourne, Sir Peter MacCallum Department of Oncology, Melbourne, VIC Australia., Canzian F; 70German Cancer Research Center (DKFZ), Genomic Epidemiology Group, Heidelberg, Germany., Castelao JE; Instituto de Investigacion Sanitaria Galicia Sur (IISGS), Xerencia de Xestion Integrada de Vigo-SERGAS, Oncology and Genetics Unit, Vigo, Spain., Chang-Claude J; German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany.; 72University Medical Center Hamburg-Eppendorf, Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), Hamburg, Germany., Chanock SJ; 16National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Division of Cancer Epidemiology and Genetics, Bethesda, MD USA., Claes KBM; 73Ghent University, Centre for Medical Genetics, Gent, Belgium., Clarke CL; 74University of Sydney, Westmead Institute for Medical Research, Sydney, NSW Australia., Collavoli A; University and University Hospital of Pisa, Section of Genetic Oncology, Dept. of Laboratory Medicine, Pisa, Italy., Conner TA; 76Huntsman Cancer Institute, Salt Lake City, UT USA., Cox DG; 77Imperial College London, Department of Epidemiology and Biostatistics, School of Public Health, London, UK.; 78Cancer Research Center of Lyon, INSERM, U1052 Lyon, France., Cybulski C; 79Pomeranian Medical University, Department of Genetics and Pathology, Szczecin, Poland., Czene K; 80Karolinska Institutet, Department of Medical Epidemiology and Biostatistics, Stockholm, Sweden., Daly MB; 81Fox Chase Cancer Center, Department of Clinical Genetics, Philadelphia, PA USA., de la Hoya M; 64Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Medical Oncology Department, Hospital Clínico San Carlos, Madrid, Spain., Devilee P; 82Leiden University Medical Center, Department of Pathology, Leiden, The Netherlands.; 83Leiden University Medical Center, Department of Human Genetics, Leiden, The Netherlands., Diez O; 84Vall d'Hebron Institute of Oncology (VHIO), Oncogenetics Group, Barcelona, Spain.; 85University Hospital Vall d'Hebron, Area of Clinical and Molecular Genetics, Barcelona, Spain., Ding YC; 86Beckman Research Institute of City of Hope, Department of Population Sciences, Duarte, CA USA., Dite GS; 87The University of Melbourne, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, Melbourne, Victoria, Australia., Ditsch N; 88Ludwig Maximilian University of Munich, Department of Gynecology and Obstetrics, Munich, Germany., Domchek SM; Perelman School of Medicine at the University of Pennsylvania, Department of Medicine, Abramson Cancer Center, Philadelphia, PA USA., Dorfling CM; 90University of Pretoria, Department of Genetics, Arcadia, South Africa., Dos-Santos-Silva I; 91London School of Hygiene and Tropical Medicine, Department of Non-Communicable Disease Epidemiology, London, UK., Durda K; 79Pomeranian Medical University, Department of Genetics and Pathology, Szczecin, Poland., Dwek M; 92University of Westminster, Department of Biomedical Sciences, Faculty of Science and Technology, London, UK., Eccles DM; 93University of Southampton, Cancer Sciences Academic Unit, Faculty of Medicine, Southampton, UK., Ekici AB; Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Institute of Human Genetics, University Hospital Erlangen, Erlangen, Germany., Eliassen AH; 95Harvard Medical School, Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA USA.; 96Harvard T.H. Chan School of Public Health, Department of Epidemiology, Boston, MA USA., Ellberg C; 97Lund University, Department of Cancer Epidemiology, Clinical Sciences, Lund, Sweden., Eriksson M; 80Karolinska Institutet, Department of Medical Epidemiology and Biostatistics, Stockholm, Sweden., Evans DG; 98University of Manchester, Division of Evolution and Genomic Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester, UK.; 99Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester Centre for Genomic Medicine, Manchester, UK., Fasching PA; University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, Erlangen, Germany.; 100University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, Los Angeles, CA USA., Figueroa J; 16National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Division of Cancer Epidemiology and Genetics, Bethesda, MD USA.; 101The University of Edinburgh Medical School, Usher Institute of Population Health Sciences and Informatics, Edinburgh, UK.; Cancer Research UK Edinburgh Centre, Edinburgh, UK., Flyger H; Copenhagen University Hospital, Department of Breast Surgery, Herlev and Gentofte Hospital, Herlev, Denmark., Foulkes WD; 104McGill University, Program in Cancer Genetics, Departments of Human Genetics and Oncology, Montréal, QC Canada., Friebel TM; 105Harvard T.H. Chan School of Public Health, Boston, MA USA.; 106Dana-Farber Cancer Institute, Boston, MA USA., Friedman E; 107Chaim Sheba Medical Center, The Susanne Levy Gertner Oncogenetics Unit, Ramat Gan, Israel.; 108Tel Aviv University, Sackler Faculty of Medicine, Ramat Aviv, Israel., Gabrielson M; 80Karolinska Institutet, Department of Medical Epidemiology and Biostatistics, Stockholm, Sweden., Gaddam P; 109Memorial Sloan-Kettering Cancer Center, Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, New York, NY USA., Gago-Dominguez M; 110Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, Genomic Medicine Group, Galician Foundation of Genomic Medicine, Santiago de Compostela, Spain.; 111University of California San Diego, Moores Cancer Center, La Jolla, CA USA., Gao C; 112Harvard T.H. Chan School of Public Health, Program in Genetic Epidemiology and Statistical Genetics, Boston, MA USA., Gapstur SM; 113American Cancer Society, Epidemiology Research Program, Atlanta, GA USA., Garber J; Dana-Farber Cancer Institute, Cancer Risk and Prevention Clinic, Boston, MA USA., García-Closas M; 16National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Division of Cancer Epidemiology and Genetics, Bethesda, MD USA., García-Sáenz JA; 64Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Medical Oncology Department, Hospital Clínico San Carlos, Madrid, Spain., Gaudet MM; 113American Cancer Society, Epidemiology Research Program, Atlanta, GA USA., Gayther SA; 116Cedars-Sinai Medical Center, The Center for Bioinformatics and Functional Genomics at the Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA USA., Giles GG; 87The University of Melbourne, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, Melbourne, Victoria, Australia.; 117Cancer Council Victoria, Cancer Epidemiology Division, Melbourne, VIC Australia.; 118Monash University, Department of Epidemiology and Preventive Medicine, Melbourne, VIC Australia., Glendon G; 119Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Fred A. Litwin Center for Cancer Genetics, Toronto, ON Canada., Godwin AK; 120Kansas University Medical Center, Department of Pathology and Laboratory Medicine, Kansas City, KS USA., Goldberg MS; 121McGill University, Department of Medicine, Montréal, QC Canada.; 122McGill University, Division of Clinical Epidemiology, Royal Victoria Hospital, Montréal, QC Canada., Goldgar DE; 123Huntsman Cancer Institute, University of Utah School of Medicine, Department of Dermatology, Salt Lake City, UT USA., Guénel P; 124INSERM, University Paris-Sud, University Paris-Saclay, Cancer & Environment Group, Center for Research in Epidemiology and Population Health (CESP), Villejuif, France., Gutierrez-Barrera AM; 125University of Texas MD Anderson Cancer Center, Department of Breast Medical Oncology and Clinical Genetics Program, Houston, TX USA., Haeberle L; 126Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Department of Gynaecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany., Haiman CA; 127University of Southern California, Department of Preventive Medicine, Keck School of Medicine, Los Angeles, CA USA., Håkansson N; 128Karolinska Institutet, Institute of Environmental Medicine, Stockholm, Sweden., Hall P; 80Karolinska Institutet, Department of Medical Epidemiology and Biostatistics, Stockholm, Sweden.; 129Södersjukhuset, Department of Oncology, Stockholm, Sweden., Hamann U; German Cancer Research Center (DKFZ), Molecular Genetics of Breast Cancer, Heidelberg, Germany., Harrington PA; 131University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Oncology, Cambridge, UK., Hein A; University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, Erlangen, Germany., Heyworth J; 132The University of Western Australia, School of Population and Global Health, Perth, WA Australia., Hillemanns P; Hannover Medical School, Gynaecology Research Unit, Hannover, Germany., Hollestelle A; 133Erasmus MC Cancer Institute, Department of Medical Oncology, Family Cancer Clinic, Rotterdam, The Netherlands., Hopper JL; 87The University of Melbourne, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, Melbourne, Victoria, Australia., Hosgood HD 3rd; 134Albert Einstein College of Medicine, Department of Epidemiology and Public Health, Bronx, NY USA., Howell A; 135University of Manchester, Division of Cancer Sciences, Manchester, UK., Hu C; 136Mayo Clinic, Department of Laboratory Medicine and Pathology, Rochester, MN USA., Hulick PJ; 137NorthShore University HealthSystem, Center for Medical Genetics, Evanston, IL USA.; 138The University of Chicago Pritzker School of Medicine, Chicago, IL USA., Hunter DJ; 96Harvard T.H. Chan School of Public Health, Department of Epidemiology, Boston, MA USA.; 112Harvard T.H. Chan School of Public Health, Program in Genetic Epidemiology and Statistical Genetics, Boston, MA USA.; 139University of Oxford, Nuffield Department of Population Health, Oxford, UK., Imyanitov EN; 140N.N. Petrov Institute of Oncology, St. Petersburg, Russia., Isaacs C; 141Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC USA., Jakimovska M; 142Macedonian Academy of Sciences and Arts, Research Centre for Genetic Engineering and Biotechnology 'Georgi D. Efremov', Skopje, Republic of Macedonia., Jakubowska A; 79Pomeranian Medical University, Department of Genetics and Pathology, Szczecin, Poland.; 143Pomeranian Medical University, Independent Laboratory of Molecular Biology and Genetic Diagnostics, Szczecin, Poland., James P; 69The University of Melbourne, Sir Peter MacCallum Department of Oncology, Melbourne, VIC Australia.; 144Peter MacCallum Cancer Center, Parkville Familial Cancer Centre, Melbourne, VIC Australia., Janavicius R; 145Vilnius University Hospital Santariskiu Clinics, Hematology, oncology and transfusion medicine center, Dept. of Molecular and Regenerative Medicine, Vilnius, Lithuania.; State Research Institute Innovative Medicine Center, Vilnius, Lithuania., Janni W; 147University Hospital Ulm, Department of Gynaecology and Obstetrics, Ulm, Germany., John EM; 148Stanford University School of Medicine, Department of Medicine (Oncology) and Stanford Cancer Institute, Stanford, CA USA., Jones ME; 115The Institute of Cancer Research, Division of Genetics and Epidemiology, London, UK., Jung A; German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany., Kaaks R; German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany., Karlan BY; 149Cedars-Sinai Medical Center, Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA USA., Khusnutdinova E; 43Ufa Federal Research Center of the Russian Academy of Sciences, Institute of Biochemistry and Genetics, Ufa, Russia.; 150Bashkir State Medical University, Department of Medical Genetics, Ufa, Russia., Kitahara CM; 151National Cancer Institute, Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, Bethesda, MD USA., Konstantopoulou I; 152National Centre for Scientific Research 'Demokritos', Molecular Diagnostics Laboratory, INRASTES, Athens, Greece., Koutros S; 16National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Division of Cancer Epidemiology and Genetics, Bethesda, MD USA., Kraft P; 96Harvard T.H. Chan School of Public Health, Department of Epidemiology, Boston, MA USA.; 112Harvard T.H. Chan School of Public Health, Program in Genetic Epidemiology and Statistical Genetics, Boston, MA USA., Lambrechts D; 153VIB, VIB Center for Cancer Biology, Leuven, Belgium.; 154University of Leuven, Laboratory for Translational Genetics, Department of Human Genetics, Leuven, Belgium., Lazaro C; IDIBELL (Bellvitge Biomedical Research Institute),Catalan Institute of Oncology, CIBERONC, Molecular Diagnostic Unit, Hereditary Cancer Program, Barcelona, Spain., Le Marchand L; 156University of Hawaii Cancer Center, Epidemiology Program, Honolulu, HI USA., Lester J; 149Cedars-Sinai Medical Center, Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA USA., Lesueur F; Inserm U900, Genetic Epidemiology of Cancer team, Paris, France.; 158PSL University, Paris, France.; 159Institut Curie, Paris, France.; 160Mines ParisTech, Fontainebleau, France., Lilyquist J; 161Mayo Clinic, Department of Health Sciences Research, Rochester, MN USA., Loud JT; 162National Cancer Institute, Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, Bethesda, MD USA., Lu KH; 163University of Texas MD Anderson Cancer Center, Department of Gynecologic Oncology and Clinical Cancer Genetics Program, Houston, TX USA., Luben RN; 164University of Cambridge, Clinical Gerontology, Department of Public Health and Primary Care, Cambridge, UK., Lubinski J; 79Pomeranian Medical University, Department of Genetics and Pathology, Szczecin, Poland., Mannermaa A; 30University of Eastern Finland, Translational Cancer Research Area, Kuopio, Finland.; 165University of Eastern Finland, Institute of Clinical Medicine, Pathology and Forensic Medicine, Kuopio, Finland.; 166Kuopio University Hospital, Imaging Center, Department of Clinical Pathology, Kuopio, Finland., Manoochehri M; German Cancer Research Center (DKFZ), Molecular Genetics of Breast Cancer, Heidelberg, Germany., Manoukian S; 31Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Department of Medical Oncology and Hematology, Unit of Medical Genetics, Milan, Italy., Margolin S; 129Södersjukhuset, Department of Oncology, Stockholm, Sweden.; Karolinska Institutet, Department of Clinical Science and Education, Södersjukhuset, Stockholm, Sweden., Martens JWM; 133Erasmus MC Cancer Institute, Department of Medical Oncology, Family Cancer Clinic, Rotterdam, The Netherlands., Maurer T; 72University Medical Center Hamburg-Eppendorf, Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), Hamburg, Germany., Mavroudis D; 168University Hospital of Heraklion, Department of Medical Oncology, Heraklion, Greece., Mebirouk N; Inserm U900, Genetic Epidemiology of Cancer team, Paris, France.; 158PSL University, Paris, France.; 159Institut Curie, Paris, France.; 160Mines ParisTech, Fontainebleau, France., Meindl A; 88Ludwig Maximilian University of Munich, Department of Gynecology and Obstetrics, Munich, Germany., Menon U; University College London, MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, London, UK., Miller A; Roswell Park Cancer Institute, NRG Oncology, Clinical Trials Development Division, Buffalo, NY USA., Montagna M; Veneto Institute of Oncology IOV - IRCCS, Immunology and Molecular Oncology Unit, Padua, Italy., Nathanson KL; Perelman School of Medicine at the University of Pennsylvania, Department of Medicine, Abramson Cancer Center, Philadelphia, PA USA., Neuhausen SL; 86Beckman Research Institute of City of Hope, Department of Population Sciences, Duarte, CA USA., Newman WG; 98University of Manchester, Division of Evolution and Genomic Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester, UK.; 99Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester Centre for Genomic Medicine, Manchester, UK., Nguyen-Dumont T; 171Monash University, Precision Medicine, School of Clinical Sciences at Monash Health, Clayton, VIC Australia.; 199The University of Melbourne, Department of Clinical Pathology, Melbourne, VIC Australia., Nielsen FC; Rigshospitalet, Copenhagen University Hospital, Center for Genomic Medicine, Copenhagen, Denmark., Nielsen S; The University of Chicago, Center for Clinical Cancer Genetics, Chicago, IL USA., Nikitina-Zake L; 174Latvian Biomedical Research and Study Centre, Riga, Latvia., Offit K; 109Memorial Sloan-Kettering Cancer Center, Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, New York, NY USA.; 175Memorial Sloan-Kettering Cancer Center, Clinical Genetics Service, Department of Medicine, New York, NY USA., Olah E; 176National Institute of Oncology, Department of Molecular Genetics, Budapest, Hungary., Olopade OI; The University of Chicago, Center for Clinical Cancer Genetics, Chicago, IL USA., Olshan AF; 177University of North Carolina at Chapel Hill, Department of Epidemiology, Lineberger Comprehensive Cancer Center, Chapel Hill, NC USA., Olson JE; 161Mayo Clinic, Department of Health Sciences Research, Rochester, MN USA., Olsson H; 97Lund University, Department of Cancer Epidemiology, Clinical Sciences, Lund, Sweden., Osorio A; Spanish National Cancer Research Centre (CNIO), Human Genetics Group, Human Cancer Genetics Programme, Madrid, Spain.; 40Spanish Network on Rare Diseases (CIBERER), Madrid, Spain., Ottini L; 178University La Sapienza, Department of Molecular Medicine, Rome, Italy., Peissel B; 31Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Department of Medical Oncology and Hematology, Unit of Medical Genetics, Milan, Italy., Peixoto A; 179Portuguese Oncology Institute, Department of Genetics, Porto, Portugal., Peto J; 91London School of Hygiene and Tropical Medicine, Department of Non-Communicable Disease Epidemiology, London, UK., Plaseska-Karanfilska D; 142Macedonian Academy of Sciences and Arts, Research Centre for Genetic Engineering and Biotechnology 'Georgi D. Efremov', Skopje, Republic of Macedonia., Pocza T; 176National Institute of Oncology, Department of Molecular Genetics, Budapest, Hungary., Presneau N; 92University of Westminster, Department of Biomedical Sciences, Faculty of Science and Technology, London, UK., Pujana MA; IDIBELL (Bellvitge Biomedical Research Institute),Catalan Institute of Oncology, CIBERONC, ProCURE, Oncobell, Barcelona, Spain., Punie K; 181Leuven Cancer Institute, University Hospitals Leuven, Multidisciplinary Breast Center, Department of General Medical Oncology, Leuven, Belgium., Rack B; 147University Hospital Ulm, Department of Gynaecology and Obstetrics, Ulm, Germany., Rantala J; 182Karolinska Institutet, Clinical Genetics, Stockholm, Sweden., Rashid MU; German Cancer Research Center (DKFZ), Molecular Genetics of Breast Cancer, Heidelberg, Germany.; 183Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH & RC), Department of Basic Sciences, Lahore, Pakistan., Rau-Murthy R; 175Memorial Sloan-Kettering Cancer Center, Clinical Genetics Service, Department of Medicine, New York, NY USA., Rennert G; 184Carmel Medical Center and Technion Faculty of Medicine, Clalit National Cancer Control Center, Haifa, Israel., Lejbkowicz F; 184Carmel Medical Center and Technion Faculty of Medicine, Clalit National Cancer Control Center, Haifa, Israel., Rhenius V; 131University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Oncology, Cambridge, UK., Romero A; 185Hospital Universitario Puerta de Hierro, Medical Oncology Department, Madrid, Spain., Rookus MA; 186The Netherlands Cancer Institute, Department of Epidemiology, Amsterdam, The Netherlands., Ross EA; 187Fox Chase Cancer Center, Biostatistics and Bioinformatics Facility, Philadelphia, PA USA., Rossing M; Rigshospitalet, Copenhagen University Hospital, Center for Genomic Medicine, Copenhagen, Denmark., Rudaitis V; 188Vilnius University, Medical Faculty, Institute of Clinical Medicine, Vilnius, Lithuania., Ruebner M; 126Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Department of Gynaecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany., Saloustros E; 189University Hospital of Larissa, Department of Oncology, Larissa, Greece., Sanden K; 190University of Wisconsin, Cancer Center at ProHealth Care, Waukesha, WI USA., Santamariña M; 40Spanish Network on Rare Diseases (CIBERER), Madrid, Spain.; 191Fundación Pública Galega Medicina Xenómica, Santiago De Compostela, Spain.; 192Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago De Compostela, Spain., Scheuner MT; 44University of California San Francisco, Cancer Genetics and Prevention Program, San Francisco, CA USA., Schmutzler RK; 193University Hospital of Cologne, Center for Hereditary Breast and Ovarian Cancer, Cologne, Germany.; 194University of Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, Germany., Schneider M; 126Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Department of Gynaecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany., Scott C; 161Mayo Clinic, Department of Health Sciences Research, Rochester, MN USA., Senter L; 195The Ohio State University, Clinical Cancer Genetics Program, Division of Human Genetics, Department of Internal Medicine, The Comprehensive Cancer Center, Columbus, OH USA., Shah M; 131University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Oncology, Cambridge, UK., Sharma P; 196University of Kansas Medical Center, Department of Internal Medicine, Division of Oncology, Westwood, KS USA., Shu XO; Vanderbilt University School of Medicine, Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Nashville, TN USA., Simard J; 36Centre Hospitalier Universitaire de Québec - Université Laval, Research Center, Genomics Center, Québec City, QC Canada., Singer CF; 26Medical University of Vienna, Dept of OB/GYN and Comprehensive Cancer Center, Vienna, Austria., Sohn C; University of Heidelberg, National Center for Tumor Diseases, Heidelberg, Germany., Soucy P; 36Centre Hospitalier Universitaire de Québec - Université Laval, Research Center, Genomics Center, Québec City, QC Canada., Southey MC; 171Monash University, Precision Medicine, School of Clinical Sciences at Monash Health, Clayton, VIC Australia.; 199The University of Melbourne, Department of Clinical Pathology, Melbourne, VIC Australia., Spinelli JJ; BC Cancer, Population Oncology, Vancouver, BC Canada.; 201University of British Columbia, School of Population and Public Health, Vancouver, BC Canada., Steele L; 86Beckman Research Institute of City of Hope, Department of Population Sciences, Duarte, CA USA., Stoppa-Lyonnet D; 202Institut Curie, Service de Génétique, Paris, France.; INSERM U830, Department of Tumour Biology, Paris, France.; 204Université Paris Descartes, Paris, France., Tapper WJ; 205University of Southampton, Faculty of Medicine, Southampton, UK., Teixeira MR; 179Portuguese Oncology Institute, Department of Genetics, Porto, Portugal.; 206University of Porto, Biomedical Sciences Institute (ICBAS), Porto, Portugal., Terry MB; 207Columbia University, Department of Epidemiology, Mailman School of Public Health, New York, NY USA., Thomassen M; 208Odense University Hospital, Department of Clinical Genetics, Odence C, Denmark., Thompson J; 137NorthShore University HealthSystem, Center for Medical Genetics, Evanston, IL USA., Thull DL; Magee-Womens Hospital, University of Pittsburgh School of Medicine, Department of Medicine, Pittsburgh, PA USA., Tischkowitz M; 104McGill University, Program in Cancer Genetics, Departments of Human Genetics and Oncology, Montréal, QC Canada.; 210University of Cambridge, Department of Medical Genetics, Cambridge, UK., Tollenaar RAEM; 211Leiden University Medical Center, Department of Surgery, Leiden, The Netherlands., Torres D; German Cancer Research Center (DKFZ), Molecular Genetics of Breast Cancer, Heidelberg, Germany.; 212Pontificia Universidad Javeriana, Institute of Human Genetics, Bogota, Colombia., Troester MA; 177University of North Carolina at Chapel Hill, Department of Epidemiology, Lineberger Comprehensive Cancer Center, Chapel Hill, NC USA., Truong T; 124INSERM, University Paris-Sud, University Paris-Saclay, Cancer & Environment Group, Center for Research in Epidemiology and Population Health (CESP), Villejuif, France., Tung N; 213Beth Israel Deaconess Medical Center, Department of Medical Oncology, Boston, MA USA., Untch M; Helios Clinics Berlin-Buch, Department of Gynecology and Obstetrics, Berlin, Germany., Vachon CM; 161Mayo Clinic, Department of Health Sciences Research, Rochester, MN USA., van Rensburg EJ; 90University of Pretoria, Department of Genetics, Arcadia, South Africa., van Veen EM; 98University of Manchester, Division of Evolution and Genomic Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester, UK.; 99Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester Centre for Genomic Medicine, Manchester, UK., Vega A; 40Spanish Network on Rare Diseases (CIBERER), Madrid, Spain.; 191Fundación Pública Galega Medicina Xenómica, Santiago De Compostela, Spain.; 192Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago De Compostela, Spain., Viel A; 215Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Division of Functional onco-genomics and genetics, Aviano, Italy., Wappenschmidt B; 193University Hospital of Cologne, Center for Hereditary Breast and Ovarian Cancer, Cologne, Germany.; 194University of Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, Germany., Weitzel JN; 216City of Hope, Clinical Cancer Genetics, Duarte, CA USA., Wendt C; 129Södersjukhuset, Department of Oncology, Stockholm, Sweden.; Karolinska Institutet, Department of Clinical Science and Education, Södersjukhuset, Stockholm, Sweden., Wieme G; 73Ghent University, Centre for Medical Genetics, Gent, Belgium., Wolk A; 128Karolinska Institutet, Institute of Environmental Medicine, Stockholm, Sweden.; 217Uppsala University, Department of Surgical Sciences, Uppsala, Sweden., Yang XR; 16National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Division of Cancer Epidemiology and Genetics, Bethesda, MD USA., Zheng W; Vanderbilt University School of Medicine, Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Nashville, TN USA., Ziogas A; 20University of California Irvine, Department of Epidemiology, Genetic Epidemiology Research Institute, Irvine, CA USA., Zorn KK; Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA USA., Dunning AM; 131University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Oncology, Cambridge, UK., Lush M; 7University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK., Wang Q; 7University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK., McGuffog L; 7University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK., Parsons MT; 219QIMR Berghofer Medical Research Institute, Department of Genetics and Computational Biology, Brisbane, QLD Australia., Pharoah PDP; 7University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK.; 131University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Oncology, Cambridge, UK., Fostira F; 152National Centre for Scientific Research 'Demokritos', Molecular Diagnostics Laboratory, INRASTES, Athens, Greece., Toland AE; 220The Ohio State University, Department of Cancer Biology and Genetics, Columbus, OH USA., Andrulis IL; 119Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Fred A. Litwin Center for Cancer Genetics, Toronto, ON Canada.; 221University of Toronto, Department of Molecular Genetics, Toronto, ON Canada., Ramus SJ; 222University of NSW Sydney, School of Women's and Children's Health, Faculty of Medicine, Sydney, NSW Australia.; 223The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, NSW Australia., Swerdlow AJ; The Institute of Cancer Research, Division of Genetics and Epidemiology, London, UK.; The Institute of Cancer Research, Division of Breast Cancer Research, London, UK., Greene MH; 162National Cancer Institute, Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, Bethesda, MD USA., Chung WK; 226Columbia University, Departments of Pediatrics and Medicine, New York, NY USA., Milne RL; 87The University of Melbourne, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, Melbourne, Victoria, Australia.; 117Cancer Council Victoria, Cancer Epidemiology Division, Melbourne, VIC Australia.; 171Monash University, Precision Medicine, School of Clinical Sciences at Monash Health, Clayton, VIC Australia., Chenevix-Trench G; 219QIMR Berghofer Medical Research Institute, Department of Genetics and Computational Biology, Brisbane, QLD Australia., Dörk T; Hannover Medical School, Gynaecology Research Unit, Hannover, Germany., Schmidt MK; 227The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Division of Molecular Pathology, Amsterdam, The Netherlands.; 228The Netherlands Cancer Institute - Antoni van Leeuwenhoek hospital, Division of Psychosocial Research and Epidemiology, Amsterdam, The Netherlands., Easton DF; 7University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK.; 131University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Oncology, Cambridge, UK., Radice P; Fondazione IRCCS Istituto Nazionale dei Tumori, Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Milan, Italy., Hahnen E; 193University Hospital of Cologne, Center for Hereditary Breast and Ovarian Cancer, Cologne, Germany.; 194University of Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, Germany., Antoniou AC; 7University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK., Couch FJ; 136Mayo Clinic, Department of Laboratory Medicine and Pathology, Rochester, MN USA., Nevanlinna H; University of Helsinki, Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland., Surrallés J; 2Department of Genetics and Microbiology, Universitat Autònoma de Barcelona, Bellaterra, Barcelona Spain.; 3Center for Biomedical Network Research on Rare Diseases (CIBERER), Madrid, Spain.; 4Institute of Biomedical Research, Sant Pau Hospital, Barcelona, Spain.; 229Department of Genetics, Sant Pau Hospital, Barcelona, Spain., Peterlongo P; IFOM - the FIRC Institute for Molecular Oncology, Genome Diagnostics Program, Milan, Italy.

Publikováno v: NPJ breast cancer [NPJ Breast Cancer] 2019 Nov 01; Vol. 5, pp. 38. Date of Electronic Publication: 2019 Nov 01 (Print Publication: 2019).

Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine.

Autor: Weisbord SD; From the Veterans Affairs (VA) Pittsburgh Healthcare System and University of Pittsburgh School of Medicine, Pittsburgh (S.D.W., P.M.P.); University of Sydney (M.G.) and the George Institute for Global Health, University of New South Wales (M.G., A.C.), Sydney, and the Menzies School of Health Research, Darwin, NT (A.C.) - all in Australia; Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston (H.J.); Minneapolis VA Health Care System and University of Minnesota, Minneapolis (S.G., E.O.M.); VA Cooperative Studies Program Coordinating Center (S.S.T., M.B., R.F., H.W., M.A., J.M., J.K.) and the Cardiology Section (D.L.B.), VA Boston Healthcare System, and Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School (D.L.B.) - all in Boston; VA Cooperative Studies Program Pharmacy Coordinating Center, Albuquerque, NM (T.A.C.); Stanford University Department of Medicine, Palo Alto (G.M.C.), and San Francisco VA Medical Center and University of California, San Francisco, San Francisco (K.S.) - all in California; and the VA Connecticut Healthcare System and Program of Applied Translational Research, Yale University, New Haven (C.R.P.)., Gallagher M; From the Veterans Affairs (VA) Pittsburgh Healthcare System and University of Pittsburgh School of Medicine, Pittsburgh (S.D.W., P.M.P.); University of Sydney (M.G.) and the George Institute for Global Health, University of New South Wales (M.G., A.C.), Sydney, and the Menzies School of Health Research, Darwin, NT (A.C.) - all in Australia; Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston (H.J.); Minneapolis VA Health Care System and University of Minnesota, Minneapolis (S.G., E.O.M.); VA Cooperative Studies Program Coordinating Center (S.S.T., M.B., R.F., H.W., M.A., J.M., J.K.) and the Cardiology Section (D.L.B.), VA Boston Healthcare System, and Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School (D.L.B.) - all in Boston; VA Cooperative Studies Program Pharmacy Coordinating Center, Albuquerque, NM (T.A.C.); Stanford University Department of Medicine, Palo Alto (G.M.C.), and San Francisco VA Medical Center and University of California, San Francisco, San Francisco (K.S.) - all in California; and the VA Connecticut Healthcare System and Program of Applied Translational Research, Yale University, New Haven (C.R.P.)., Jneid H; From the Veterans Affairs (VA) Pittsburgh Healthcare System and University of Pittsburgh School of Medicine, Pittsburgh (S.D.W., P.M.P.); University of Sydney (M.G.) and the George Institute for Global Health, University of New South Wales (M.G., A.C.), Sydney, and the Menzies School of Health Research, Darwin, NT (A.C.) - all in Australia; Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston (H.J.); Minneapolis VA Health Care System and University of Minnesota, Minneapolis (S.G., E.O.M.); VA Cooperative Studies Program Coordinating Center (S.S.T., M.B., R.F., H.W., M.A., J.M., J.K.) and the Cardiology Section (D.L.B.), VA Boston Healthcare System, and Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School (D.L.B.) - all in Boston; VA Cooperative Studies Program Pharmacy Coordinating Center, Albuquerque, NM (T.A.C.); Stanford University Department of Medicine, Palo Alto (G.M.C.), and San Francisco VA Medical Center and University of California, San Francisco, San Francisco (K.S.) - all in California; and the VA Connecticut Healthcare System and Program of Applied Translational Research, Yale University, New Haven (C.R.P.)., Garcia S; From the Veterans Affairs (VA) Pittsburgh Healthcare System and University of Pittsburgh School of Medicine, Pittsburgh (S.D.W., P.M.P.); University of Sydney (M.G.) and the George Institute for Global Health, University of New South Wales (M.G., A.C.), Sydney, and the Menzies School of Health Research, Darwin, NT (A.C.) - all in Australia; Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston (H.J.); Minneapolis VA Health Care System and University of Minnesota, Minneapolis (S.G., E.O.M.); VA Cooperative Studies Program Coordinating Center (S.S.T., M.B., R.F., H.W., M.A., J.M., J.K.) and the Cardiology Section (D.L.B.), VA Boston Healthcare System, and Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School (D.L.B.) - all in Boston; VA Cooperative Studies Program Pharmacy Coordinating Center, Albuquerque, NM (T.A.C.); Stanford University Department of Medicine, Palo Alto (G.M.C.), and San Francisco VA Medical Center and University of California, San Francisco, San Francisco (K.S.) - all in California; and the VA Connecticut Healthcare System and Program of Applied Translational Research, Yale University, New Haven (C.R.P.)., Cass A; From the Veterans Affairs (VA) Pittsburgh Healthcare System and University of Pittsburgh School of Medicine, Pittsburgh (S.D.W., P.M.P.); University of Sydney (M.G.) and the George Institute for Global Health, University of New South Wales (M.G., A.C.), Sydney, and the Menzies School of Health Research, Darwin, NT (A.C.) - all in Australia; Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston (H.J.); Minneapolis VA Health Care System and University of Minnesota, Minneapolis (S.G., E.O.M.); VA Cooperative Studies Program Coordinating Center (S.S.T., M.B., R.F., H.W., M.A., J.M., J.K.) and the Cardiology Section (D.L.B.), VA Boston Healthcare System, and Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School (D.L.B.) - all in Boston; VA Cooperative Studies Program Pharmacy Coordinating Center, Albuquerque, NM (T.A.C.); Stanford University Department of Medicine, Palo Alto (G.M.C.), and San Francisco VA Medical Center and University of California, San Francisco, San Francisco (K.S.) - all in California; and the VA Connecticut Healthcare System and Program of Applied Translational Research, Yale University, New Haven (C.R.P.)., Thwin SS; From the Veterans Affairs (VA) Pittsburgh Healthcare System and University of Pittsburgh School of Medicine, Pittsburgh (S.D.W., P.M.P.); University of Sydney (M.G.) and the George Institute for Global Health, University of New South Wales (M.G., A.C.), Sydney, and the Menzies School of Health Research, Darwin, NT (A.C.) - all in Australia; Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston (H.J.); Minneapolis VA Health Care System and University of Minnesota, Minneapolis (S.G., E.O.M.); VA Cooperative Studies Program Coordinating Center (S.S.T., M.B., R.F., H.W., M.A., J.M., J.K.) and the Cardiology Section (D.L.B.), VA Boston Healthcare System, and Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School (D.L.B.) - all in Boston; VA Cooperative Studies Program Pharmacy Coordinating Center, Albuquerque, NM (T.A.C.); Stanford University Department of Medicine, Palo Alto (G.M.C.), and San Francisco VA Medical Center and University of California, San Francisco, San Francisco (K.S.) - all in California; and the VA Connecticut Healthcare System and Program of Applied Translational Research, Yale University, New Haven (C.R.P.)., Conner TA; From the Veterans Affairs (VA) Pittsburgh Healthcare System and University of Pittsburgh School of Medicine, Pittsburgh (S.D.W., P.M.P.); University of Sydney (M.G.) and the George Institute for Global Health, University of New South Wales (M.G., A.C.), Sydney, and the Menzies School of Health Research, Darwin, NT (A.C.) - all in Australia; Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston (H.J.); Minneapolis VA Health Care System and University of Minnesota, Minneapolis (S.G., E.O.M.); VA Cooperative Studies Program Coordinating Center (S.S.T., M.B., R.F., H.W., M.A., J.M., J.K.) and the Cardiology Section (D.L.B.), VA Boston Healthcare System, and Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School (D.L.B.) - all in Boston; VA Cooperative Studies Program Pharmacy Coordinating Center, Albuquerque, NM (T.A.C.); Stanford University Department of Medicine, Palo Alto (G.M.C.), and San Francisco VA Medical Center and University of California, San Francisco, San Francisco (K.S.) - all in California; and the VA Connecticut Healthcare System and Program of Applied Translational Research, Yale University, New Haven (C.R.P.)., Chertow GM; From the Veterans Affairs (VA) Pittsburgh Healthcare System and University of Pittsburgh School of Medicine, Pittsburgh (S.D.W., P.M.P.); University of Sydney (M.G.) and the George Institute for Global Health, University of New South Wales (M.G., A.C.), Sydney, and the Menzies School of Health Research, Darwin, NT (A.C.) - all in Australia; Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston (H.J.); Minneapolis VA Health Care System and University of Minnesota, Minneapolis (S.G., E.O.M.); VA Cooperative Studies Program Coordinating Center (S.S.T., M.B., R.F., H.W., M.A., J.M., J.K.) and the Cardiology Section (D.L.B.), VA Boston Healthcare System, and Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School (D.L.B.) - all in Boston; VA Cooperative Studies Program Pharmacy Coordinating Center, Albuquerque, NM (T.A.C.); Stanford University Department of Medicine, Palo Alto (G.M.C.), and San Francisco VA Medical Center and University of California, San Francisco, San Francisco (K.S.) - all in California; and the VA Connecticut Healthcare System and Program of Applied Translational Research, Yale University, New Haven (C.R.P.)., Bhatt DL; From the Veterans Affairs (VA) Pittsburgh Healthcare System and University of Pittsburgh School of Medicine, Pittsburgh (S.D.W., P.M.P.); University of Sydney (M.G.) and the George Institute for Global Health, University of New South Wales (M.G., A.C.), Sydney, and the Menzies School of Health Research, Darwin, NT (A.C.) - all in Australia; Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston (H.J.); Minneapolis VA Health Care System and University of Minnesota, Minneapolis (S.G., E.O.M.); VA Cooperative Studies Program Coordinating Center (S.S.T., M.B., R.F., H.W., M.A., J.M., J.K.) and the Cardiology Section (D.L.B.), VA Boston Healthcare System, and Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School (D.L.B.) - all in Boston; VA Cooperative Studies Program Pharmacy Coordinating Center, Albuquerque, NM (T.A.C.); Stanford University Department of Medicine, Palo Alto (G.M.C.), and San Francisco VA Medical Center and University of California, San Francisco, San Francisco (K.S.) - all in California; and the VA Connecticut Healthcare System and Program of Applied Translational Research, Yale University, New Haven (C.R.P.)., Shunk K; From the Veterans Affairs (VA) Pittsburgh Healthcare System and University of Pittsburgh School of Medicine, Pittsburgh (S.D.W., P.M.P.); University of Sydney (M.G.) and the George Institute for Global Health, University of New South Wales (M.G., A.C.), Sydney, and the Menzies School of Health Research, Darwin, NT (A.C.) - all in Australia; Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston (H.J.); Minneapolis VA Health Care System and University of Minnesota, Minneapolis (S.G., E.O.M.); VA Cooperative Studies Program Coordinating Center (S.S.T., M.B., R.F., H.W., M.A., J.M., J.K.) and the Cardiology Section (D.L.B.), VA Boston Healthcare System, and Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School (D.L.B.) - all in Boston; VA Cooperative Studies Program Pharmacy Coordinating Center, Albuquerque, NM (T.A.C.); Stanford University Department of Medicine, Palo Alto (G.M.C.), and San Francisco VA Medical Center and University of California, San Francisco, San Francisco (K.S.) - all in California; and the VA Connecticut Healthcare System and Program of Applied Translational Research, Yale University, New Haven (C.R.P.)., Parikh CR; From the Veterans Affairs (VA) Pittsburgh Healthcare System and University of Pittsburgh School of Medicine, Pittsburgh (S.D.W., P.M.P.); University of Sydney (M.G.) and the George Institute for Global Health, University of New South Wales (M.G., A.C.), Sydney, and the Menzies School of Health Research, Darwin, NT (A.C.) - all in Australia; Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston (H.J.); Minneapolis VA Health Care System and University of Minnesota, Minneapolis (S.G., E.O.M.); VA Cooperative Studies Program Coordinating Center (S.S.T., M.B., R.F., H.W., M.A., J.M., J.K.) and the Cardiology Section (D.L.B.), VA Boston Healthcare System, and Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School (D.L.B.) - all in Boston; VA Cooperative Studies Program Pharmacy Coordinating Center, Albuquerque, NM (T.A.C.); Stanford University Department of Medicine, Palo Alto (G.M.C.), and San Francisco VA Medical Center and University of California, San Francisco, San Francisco (K.S.) - all in California; and the VA Connecticut Healthcare System and Program of Applied Translational Research, Yale University, New Haven (C.R.P.)., McFalls EO; From the Veterans Affairs (VA) Pittsburgh Healthcare System and University of Pittsburgh School of Medicine, Pittsburgh (S.D.W., P.M.P.); University of Sydney (M.G.) and the George Institute for Global Health, University of New South Wales (M.G., A.C.), Sydney, and the Menzies School of Health Research, Darwin, NT (A.C.) - all in Australia; Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston (H.J.); Minneapolis VA Health Care System and University of Minnesota, Minneapolis (S.G., E.O.M.); VA Cooperative Studies Program Coordinating Center (S.S.T., M.B., R.F., H.W., M.A., J.M., J.K.) and the Cardiology Section (D.L.B.), VA Boston Healthcare System, and Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School (D.L.B.) - all in Boston; VA Cooperative Studies Program Pharmacy Coordinating Center, Albuquerque, NM (T.A.C.); Stanford University Department of Medicine, Palo Alto (G.M.C.), and San Francisco VA Medical Center and University of California, San Francisco, San Francisco (K.S.) - all in California; and the VA Connecticut Healthcare System and Program of Applied Translational Research, Yale University, New Haven (C.R.P.)., Brophy M; From the Veterans Affairs (VA) Pittsburgh Healthcare System and University of Pittsburgh School of Medicine, Pittsburgh (S.D.W., P.M.P.); University of Sydney (M.G.) and the George Institute for Global Health, University of New South Wales (M.G., A.C.), Sydney, and the Menzies School of Health Research, Darwin, NT (A.C.) - all in Australia; Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston (H.J.); Minneapolis VA Health Care System and University of Minnesota, Minneapolis (S.G., E.O.M.); VA Cooperative Studies Program Coordinating Center (S.S.T., M.B., R.F., H.W., M.A., J.M., J.K.) and the Cardiology Section (D.L.B.), VA Boston Healthcare System, and Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School (D.L.B.) - all in Boston; VA Cooperative Studies Program Pharmacy Coordinating Center, Albuquerque, NM (T.A.C.); Stanford University Department of Medicine, Palo Alto (G.M.C.), and San Francisco VA Medical Center and University of California, San Francisco, San Francisco (K.S.) - all in California; and the VA Connecticut Healthcare System and Program of Applied Translational Research, Yale University, New Haven (C.R.P.)., Ferguson R; From the Veterans Affairs (VA) Pittsburgh Healthcare System and University of Pittsburgh School of Medicine, Pittsburgh (S.D.W., P.M.P.); University of Sydney (M.G.) and the George Institute for Global Health, University of New South Wales (M.G., A.C.), Sydney, and the Menzies School of Health Research, Darwin, NT (A.C.) - all in Australia; Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston (H.J.); Minneapolis VA Health Care System and University of Minnesota, Minneapolis (S.G., E.O.M.); VA Cooperative Studies Program Coordinating Center (S.S.T., M.B., R.F., H.W., M.A., J.M., J.K.) and the Cardiology Section (D.L.B.), VA Boston Healthcare System, and Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School (D.L.B.) - all in Boston; VA Cooperative Studies Program Pharmacy Coordinating Center, Albuquerque, NM (T.A.C.); Stanford University Department of Medicine, Palo Alto (G.M.C.), and San Francisco VA Medical Center and University of California, San Francisco, San Francisco (K.S.) - all in California; and the VA Connecticut Healthcare System and Program of Applied Translational Research, Yale University, New Haven (C.R.P.)., Wu H; From the Veterans Affairs (VA) Pittsburgh Healthcare System and University of Pittsburgh School of Medicine, Pittsburgh (S.D.W., P.M.P.); University of Sydney (M.G.) and the George Institute for Global Health, University of New South Wales (M.G., A.C.), Sydney, and the Menzies School of Health Research, Darwin, NT (A.C.) - all in Australia; Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston (H.J.); Minneapolis VA Health Care System and University of Minnesota, Minneapolis (S.G., E.O.M.); VA Cooperative Studies Program Coordinating Center (S.S.T., M.B., R.F., H.W., M.A., J.M., J.K.) and the Cardiology Section (D.L.B.), VA Boston Healthcare System, and Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School (D.L.B.) - all in Boston; VA Cooperative Studies Program Pharmacy Coordinating Center, Albuquerque, NM (T.A.C.); Stanford University Department of Medicine, Palo Alto (G.M.C.), and San Francisco VA Medical Center and University of California, San Francisco, San Francisco (K.S.) - all in California; and the VA Connecticut Healthcare System and Program of Applied Translational Research, Yale University, New Haven (C.R.P.)., Androsenko M; From the Veterans Affairs (VA) Pittsburgh Healthcare System and University of Pittsburgh School of Medicine, Pittsburgh (S.D.W., P.M.P.); University of Sydney (M.G.) and the George Institute for Global Health, University of New South Wales (M.G., A.C.), Sydney, and the Menzies School of Health Research, Darwin, NT (A.C.) - all in Australia; Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston (H.J.); Minneapolis VA Health Care System and University of Minnesota, Minneapolis (S.G., E.O.M.); VA Cooperative Studies Program Coordinating Center (S.S.T., M.B., R.F., H.W., M.A., J.M., J.K.) and the Cardiology Section (D.L.B.), VA Boston Healthcare System, and Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School (D.L.B.) - all in Boston; VA Cooperative Studies Program Pharmacy Coordinating Center, Albuquerque, NM (T.A.C.); Stanford University Department of Medicine, Palo Alto (G.M.C.), and San Francisco VA Medical Center and University of California, San Francisco, San Francisco (K.S.) - all in California; and the VA Connecticut Healthcare System and Program of Applied Translational Research, Yale University, New Haven (C.R.P.)., Myles J; From the Veterans Affairs (VA) Pittsburgh Healthcare System and University of Pittsburgh School of Medicine, Pittsburgh (S.D.W., P.M.P.); University of Sydney (M.G.) and the George Institute for Global Health, University of New South Wales (M.G., A.C.), Sydney, and the Menzies School of Health Research, Darwin, NT (A.C.) - all in Australia; Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston (H.J.); Minneapolis VA Health Care System and University of Minnesota, Minneapolis (S.G., E.O.M.); VA Cooperative Studies Program Coordinating Center (S.S.T., M.B., R.F., H.W., M.A., J.M., J.K.) and the Cardiology Section (D.L.B.), VA Boston Healthcare System, and Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School (D.L.B.) - all in Boston; VA Cooperative Studies Program Pharmacy Coordinating Center, Albuquerque, NM (T.A.C.); Stanford University Department of Medicine, Palo Alto (G.M.C.), and San Francisco VA Medical Center and University of California, San Francisco, San Francisco (K.S.) - all in California; and the VA Connecticut Healthcare System and Program of Applied Translational Research, Yale University, New Haven (C.R.P.)., Kaufman J; From the Veterans Affairs (VA) Pittsburgh Healthcare System and University of Pittsburgh School of Medicine, Pittsburgh (S.D.W., P.M.P.); University of Sydney (M.G.) and the George Institute for Global Health, University of New South Wales (M.G., A.C.), Sydney, and the Menzies School of Health Research, Darwin, NT (A.C.) - all in Australia; Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston (H.J.); Minneapolis VA Health Care System and University of Minnesota, Minneapolis (S.G., E.O.M.); VA Cooperative Studies Program Coordinating Center (S.S.T., M.B., R.F., H.W., M.A., J.M., J.K.) and the Cardiology Section (D.L.B.), VA Boston Healthcare System, and Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School (D.L.B.) - all in Boston; VA Cooperative Studies Program Pharmacy Coordinating Center, Albuquerque, NM (T.A.C.); Stanford University Department of Medicine, Palo Alto (G.M.C.), and San Francisco VA Medical Center and University of California, San Francisco, San Francisco (K.S.) - all in California; and the VA Connecticut Healthcare System and Program of Applied Translational Research, Yale University, New Haven (C.R.P.)., Palevsky PM; From the Veterans Affairs (VA) Pittsburgh Healthcare System and University of Pittsburgh School of Medicine, Pittsburgh (S.D.W., P.M.P.); University of Sydney (M.G.) and the George Institute for Global Health, University of New South Wales (M.G., A.C.), Sydney, and the Menzies School of Health Research, Darwin, NT (A.C.) - all in Australia; Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston (H.J.); Minneapolis VA Health Care System and University of Minnesota, Minneapolis (S.G., E.O.M.); VA Cooperative Studies Program Coordinating Center (S.S.T., M.B., R.F., H.W., M.A., J.M., J.K.) and the Cardiology Section (D.L.B.), VA Boston Healthcare System, and Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School (D.L.B.) - all in Boston; VA Cooperative Studies Program Pharmacy Coordinating Center, Albuquerque, NM (T.A.C.); Stanford University Department of Medicine, Palo Alto (G.M.C.), and San Francisco VA Medical Center and University of California, San Francisco, San Francisco (K.S.) - all in California; and the VA Connecticut Healthcare System and Program of Applied Translational Research, Yale University, New Haven (C.R.P.).

Publikováno v: The New England journal of medicine [N Engl J Med] 2018 Feb 15; Vol. 378 (7), pp. 603-614. Date of Electronic Publication: 2017 Nov 12.